IDX Relative Valuation - Integral Diagnostics Ltd

Watchlist Manager

Watchlist

Price: 2.27 AUD Market Closed

Market Cap: AU$846.6m

	Integral Diagnostics Ltd ASX:IDX	AU

Multiples-Based Value

The Multiples-Based Value for Integral Diagnostics Ltd (IDX) under the Base Case is 4.38 AUD. Compared with the current market price of 2.27 AUD, the stock appears Undervalued by 48%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

IDX Multiples-Based Value

Base Case

Undervaluation 48%

Multiples-Based Value

Price AU$2.27

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
AU		Integral Diagnostics Ltd ASX:IDX	845.2m AUD	1.1	59.7	19.6	19.6
US		CVS Health Corp NYSE:CVS	100.8B USD	0.3	57	14.4	14.4
US	C	Cigna Group XMUN:CGN	69.6B EUR	0.3	13.4	7.8	10
US		Cigna Corp NYSE:CI	71.5B USD	0.3	12	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25.2B EUR	1.1	19.9	9.9	14.7
DE		Fresenius Medical Care AG XMUN:FME	23.7B EUR	1.2	24.2	9.3	17.1
US		Laboratory Corporation of America Holdings NYSE:LH	21.4B USD	1.5	24.5	11.8	17.1
US		Quest Diagnostics Inc NYSE:DGX	21.1B USD	1.9	21.3	11.6	15.6
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.3B EUR	0.6	11.5	5.5	10.1
US		Guardant Health Inc NASDAQ:GH	10.3B USD	10.5	-24.7	-27.1	-24.6
US		DaVita Inc NYSE:DVA	10.3B USD	0.8	13.8	7.1	9.7

				Revenue Growth	P/S to Growth
AU		Integral Diagnostics Ltd ASX:IDX	Average P/S: 1.8 1.1	13%	0.1
US		CVS Health Corp NYSE:CVS	0.3	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	2%	0.6
US		Laboratory Corporation of America Holdings NYSE:LH	1.5	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	1.9	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	2%	0.3
US		Guardant Health Inc NASDAQ:GH	10.5	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
AU		Integral Diagnostics Ltd ASX:IDX	Average P/E: 25.7 59.7	142%	0.4
US		CVS Health Corp NYSE:CVS	57	90%	0.6
US	C	Cigna Group XMUN:CGN	13.4	19%	0.7
US		Cigna Corp NYSE:CI	12	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.9	25%	0.8
DE		Fresenius Medical Care AG XMUN:FME	24.2	15%	1.6
US		Laboratory Corporation of America Holdings NYSE:LH	24.5	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.3	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.5	15%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -24.7	N/A	N/A
US		DaVita Inc NYSE:DVA	13.8	19%	0.7

				EBITDA Growth	EV/EBITDA to Growth
AU		Integral Diagnostics Ltd ASX:IDX	Average EV/EBITDA: 10.8 19.6	51%	0.4
US		CVS Health Corp NYSE:CVS	14.4	28%	0.5
US	C	Cigna Group XMUN:CGN	7.8	5%	1.6
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.9	10%	1
DE		Fresenius Medical Care AG XMUN:FME	9.3	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	11.8	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.6	6%	1.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.5	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.1	N/A	N/A
US		DaVita Inc NYSE:DVA	7.1	4%	1.8

				EBIT Growth	EV/EBIT to Growth
AU		Integral Diagnostics Ltd ASX:IDX	Average EV/EBIT: 14.3 19.6	28%	0.7
US		CVS Health Corp NYSE:CVS	14.4	22%	0.7
US	C	Cigna Group XMUN:CGN	10	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14.7	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	17.1	11%	1.6
US		Laboratory Corporation of America Holdings NYSE:LH	17.1	18%	0.9
US		Quest Diagnostics Inc NYSE:DGX	15.6	9%	1.7
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.1	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -24.6	N/A	N/A
US		DaVita Inc NYSE:DVA	9.7	5%	1.9

Integral Diagnostics Ltd
ASX:IDX

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

IDX Competitors Multiples
Integral Diagnostics Ltd Competitors

See Also

Company

Help

Tools

Stocks

Integral Diagnostics Ltd ASX:IDX

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

IDX Competitors Multiples Integral Diagnostics Ltd Competitors

See Also

Company

Help

Tools

Stocks

Integral Diagnostics Ltd
ASX:IDX

IDX Competitors Multiples
Integral Diagnostics Ltd Competitors